retatrutide triple hormone receptor agonist Phase 2 Trial of for Obesity Retatrutide, an investigational triple hormone

And the number one thing that my patients say in terms of feedback is I cannot believe how much less inflammation I have

With a range of GLP-1 injectables and personalized diet programs, patients receive the guidance and treatments they need to succeed

In markets across Asia, Africa, Latin America, and parts of Eastern Europe where cold-chain infrastructure is unreliable, oral GLP-1s have the potential to unlock access to hundreds of millions of patients who could never have reliably received injectable therapy

Underlying cardiovascular disease: Many patients prescribed GLP-1 medications have cardiovascular risk factors or established heart disease

Current incretin medicines include GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists

If you or a loved one suffered from severe stomach paralysis, bowel obstruction, ileus, or other health issues after taking Ozempic, you may be eligible to file an Ozempic lawsuit against the drug makers